Drusen subregion staining may not be linked to macula drusen in AMD

Article

Drusen subregion staining may not be directly linked to in vivo observations of macula drusen in age-related macula degeneration (AMD).

Drusen subregion staining may not be directly linked to in vivo observations of macula drusen in age-related macula degeneration (AMD), states a paper in the journal Retina.

Dr Duncan Friedman et al., Department of Ophthalmology, School of medicine, University of Alabama, Birmingham, Alabama, USA, evaluated macula drusen from 35 patients with AMD. This was completed by measuring drusen area with colour digital images and fluorescein angiograms.

In total, 828 drusen were assessed and 405 of these presented with a corresponding fluorescein angiogram signal. Drusen was stained in 49.57% of patients and drusen measured in fluorescein images did not significantly differ from drusen sizes measured by colour digital images.

The study discovered that the current understanding of drusen subregion staining is not directly linked to in vivo observations found in AMD macula drusen.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.